GGrantIndex
Sort

59,101 grants matching hypertension

TAS::75 0872::TAS PROTEOMICS OF INFLAMMATION, IMNUNITY AND PULMONARY ARTERIAL HY

$2,713,017
Garry P Nolan · Stanford University · N01 · FY2014 · HL

Therapeutic Targeting of Vascular Subphenotypes of Lung Disease

$2,713,014
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2019 · HL

JACKSON HEART STUDY (JHS) UNDERGRADUATE TRAINING AND EDUCATION CENTER (UTEC) - TASK AREA B

$2,707,787
Wendy White · Tougaloo College · N01 · FY2023 · HL

Therapeutic Targeting of Vascular Subphenotypes of Lung Disease

$2,704,375
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2016 · HL

Molecular Genetic Approaches in Atherosclerosis Research

$2,704,188
Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2016 · HL

GENERAL CLINICAL RESEARCH CENTER

$2,704,143
Thomas F Boat · Cincinnati Childrens Hosp Med Ctr · M01 · FY2006 · RR

Framingham Project/Levy

$2,703,246
Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

Genetic Epidemiological Studies of Alzheimer Disease

$2,703,183
Boston University Medical Campus · R01 · FY2004 · AG

GENERAL CLINICAL RESEARCH CENTER

$2,700,918
Weill Medical College Of Cornell Univ · M01 · FY2001 · RR

Therapeutic Targeting of Vascular Subphenotypes of Lung Disease

$2,700,395
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2017 · HL

North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal

$2,700,000
Richard Douglas Moore · Johns Hopkins University · U01 · FY2016 · AI

Complement Mediated Remodeling in Pulmonary Vascular Disease

$2,699,112
Kurt R Stenmark · University Of Colorado Denver · P01 · FY2024 · HL

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)

$2,696,667
Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2025 · DA

Yale Center for Mendelian Disorders

$2,696,444
Richard P Lifton · Yale University · U54 · FY2014 · HG

Perivascular Adipose Tissue (PVAT) as a Central Integrator of Vascular Health

$2,695,451
Stephanie W Watts · Michigan State University · P01 · FY2022 · HL

Perivascular Adipose Tissue (PVAT) as a Central Integrator of Vascular Health

$2,694,565
Stephanie W Watts · Michigan State University · P01 · FY2023 · HL

Mechanisms of sleep and sleep apnea

$2,693,865
Clifford B Saper · Beth Israel Deaconess Medical Center · P01 · FY2020 · HL

Molecular Genetic Approaches in Atherosclerosis Research

$2,693,389
Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2019 · HL

Human Trisome Project - Latin America Network

$2,693,143
Joaquin M. Espinosa · University Of Colorado Denver · U01 · FY2024 · HD

Molecular Genetic Approaches in Atherosclerosis Research

$2,691,229
Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2017 · HL

Pregnancy as a Window to Future Cardiovascular Health: Adverse Pregnancy Outcomes

$2,690,938
Corette B Parker · Research Triangle Institute · U10 · FY2013 · HL

African American Eye Disease Study

$2,689,586
Rohit Varma · University Of Southern California · U10 · FY2016 · EY

GENERAL CLINICAL RESEARCH CENTER

$2,688,678
Yale University · M01 · FY2000 · RR

Clarifying the Optimal Application of SLT Therapy (COAST) Trial

$2,679,188
Stephen R Wisniewski · University Of Pittsburgh At Pittsburgh · UG1 · FY2022 · EY

Novel population health approach to address CVD and pulmonary health disparities

$2,675,080
F Javier Nieto · University Of Wisconsin-Madison · RC2 · FY2009 · HL